Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. Signal., 25 September 2012
Vol. 5, Issue 243, p. ra68
[DOI: 10.1126/scisignal.2003021]


Superbinder SH2 Domains Act as Antagonists of Cell Signaling

Tomonori Kaneko1*, Haiming Huang2*, Xuan Cao1, Xing Li1, Chengjun Li1, Courtney Voss1, Sachdev S. Sidhu2{dagger}, and Shawn S. C. Li1{dagger}

1 Department of Biochemistry and Siebens-Drake Medical Research Institute, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario N6A 5C1, Canada.
2 Banting and Best Department of Medical Research and Department of Molecular Genetics, University of Toronto, Donnelly Centre, 160 College Street, Toronto, Ontario M5S 3E1, Canada.

* These authors contributed equally to this work.

Abstract: Protein-ligand interactions mediated by modular domains, which often play important roles in regulating cellular functions, are generally of moderate affinities. We examined the Src homology 2 (SH2) domain, a modular domain that recognizes phosphorylated tyrosine (pTyr) residues, to investigate how the binding affinity of a modular domain for its ligand influences the structure and cellular function of the protein. We used the phage display method to perform directed evolution of the pTyr-binding residues in the SH2 domain of the tyrosine kinase Fyn and identified three amino acid substitutions that critically affected binding. We generated three SH2 domain triple-point mutants that were "superbinders" with much higher affinities for pTyr-containing peptides than the natural domain. Crystallographic analysis of one of these superbinders revealed that the superbinder SH2 domain recognized the pTyr moiety in a bipartite binding mode: A hydrophobic surface encompassed the phenyl ring, and a positively charged site engaged the phosphate. When expressed in mammalian cells, the superbinder SH2 domains blocked epidermal growth factor receptor signaling and inhibited anchorage-independent cell proliferation, suggesting that pTyr superbinders might be explored for therapeutic applications and useful as biological research tools. Although the SH2 domain fold can support much higher affinity for its ligand than is observed in nature, our results suggest that natural SH2 domains are not optimized for ligand binding but for specificity and flexibility, which are likely properties important for their function in signaling and regulatory processes.

{dagger} To whom correspondence should be addressed. E-mail: sachdev.sidhu{at} (S.S.S.); sli{at} (S.S.C.L.)

Citation: T. Kaneko, H. Huang, X. Cao, X. Li, C. Li, C. Voss, S. S. Sidhu, S. S. C. Li, Superbinder SH2 Domains Act as Antagonists of Cell Signaling. Sci. Signal. 5, ra68 (2012).

Read the Full Text

Cancer-Derived Mutations in KEAP1 Impair NRF2 Degradation but not Ubiquitination.
B. E. Hast, E. W. Cloer, D. Goldfarb, H. Li, P. F. Siesser, F. Yan, V. Walter, N. Zheng, D. N. Hayes, and M. B. Major (2014)
Cancer Res. 74, 808-817
   Abstract »    Full Text »    PDF »
Cargo Recognition in Clathrin-Mediated Endocytosis.
L. M. Traub and J. S. Bonifacino (2013)
Cold Spring Harb Perspect Biol 5, a016790
   Abstract »    Full Text »    PDF »
Peptide-Binding Domains: Are Limp Handshakes Safest?.
N. J. Haslam and D. C. Shields (2012)
Science Signaling 5, pe40
   Abstract »    Full Text »    PDF »

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882